Literature DB >> 18318950

Typhoid intestinal perforation under 5 years of age.

Sebastian O Ekenze1, Anthony N Ikefuna.   

Abstract

BACKGROUND: Typhoid intestinal perforation is an important cause of morbidity and mortality in many developing countries. The peculiar features in children <5 years old need to be recognised in order to improve outcome.
OBJECTIVE: To determine the characteristic pattern and outcome of typhoid intestinal perforation in children under 5 years of age in south-east Nigeria.
METHOD: Comparative analysis of 83 children with typhoid intestinal perforation between January 2001 and December 2006 at the University of Nigeria Teaching Hospital, Enugu.
RESULTS: There were 22 (26.5%) children <5 years of age and 61 (73.5%) >5 years. In the younger children, the predominant presentation was fever, vomiting and abdominal tenderness, and in the older children it was fever, abdominal pain and distension. Features of peritonitis were present in only 54.5% aged <5 years compared with 90.2% of the older children (p<0.001). The average number of perforations in the under-5s was 2.1 (range 1-4) and >1.3 (range 1-3) in the older children (p<0.01). The types of operative procedure (simple closure and segmental bowel resection) were similar in both groups. Post-operative complications were not significantly different in the two groups and included surgical wound infection, prolonged ileus, pulmonary infection, wound dehiscence, re-perforation, intra-abdominal abscess and incisional hernia. There were nine (40.9%) deaths in the <5s and 12 (19.7%) in the >5s (p<0.05).
CONCLUSION: Typhoid intestinal perforation in children <5 is associated with atypical presentation and high mortality. A high index of suspicion will ensure earlier presentation and might improve outcome.

Entities:  

Mesh:

Year:  2008        PMID: 18318950     DOI: 10.1179/146532808X270680

Source DB:  PubMed          Journal:  Ann Trop Paediatr        ISSN: 0272-4936


  7 in total

1.  Outcome of surgical treatment of intestinal perforation in typhoid fever.

Authors:  Aziz Sümer; Ozgür Kemik; Ahmet Cumhur Dülger; Aydemir Olmez; Ismail Hasirci; Erol Kişli; Vedat Bayrak; Gulay Bulut; Cetin Kotan
Journal:  World J Gastroenterol       Date:  2010-09-07       Impact factor: 5.742

2.  Predictor of mortality in children with typhoid intestinal perforation in a Tertiary Hospital in Nigeria.

Authors:  Abdulrasheed A Nasir; Lukman O Abdur-Rahman; James O Adeniran
Journal:  Pediatr Surg Int       Date:  2011-05-19       Impact factor: 1.827

3.  Validation of the use of POSSUM score in enteric perforation peritonitis - results of a prospective study.

Authors:  Sunil Kumar; Amit Gupta; Sujata Chaudhary; Neeraj Agrawal
Journal:  Pan Afr Med J       Date:  2011-06-23

4.  Prevalence, morbidity, and mortality patterns of typhoid ileal perforation as seen at the University of Nigeria Teaching Hospital Enugu Nigeria: an 8-year review.

Authors:  Kenneth Agu; Martin Nzegwu; Emmanuel Obi
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

5.  Modifiable risk factors for typhoid intestinal perforations during a large outbreak of typhoid fever, Kampala Uganda, 2015.

Authors:  Lilian Bulage; Ben Masiira; Alex R Ario; Joseph K B Matovu; Peter Nsubuga; Frank Kaharuza; Victoria Nankabirwa; Janell Routh; Bao-Ping Zhu
Journal:  BMC Infect Dis       Date:  2017-09-25       Impact factor: 3.090

Review 6.  Morbidity and Mortality of Typhoid Intestinal Perforation Among Children in Sub-Saharan Africa 1995-2019: A Scoping Review.

Authors:  Megan Birkhold; Yacaria Coulibaly; Oumar Coulibaly; Philadelphie Dembélé; Daniel S Kim; Samba Sow; Kathleen M Neuzil
Journal:  World J Surg       Date:  2020-09       Impact factor: 3.352

7.  Surge of Typhoid Intestinal Perforations as Possible Result of COVID-19-Associated Delays in Seeking Care, Madagascar.

Authors:  Hyon Jin Jeon; Florian Marks; Jonathan Sugimoto; Justin Im; Sophie S Y Kang; Andrea Haselbeck; Raphaël Rakotozandrindrainy
Journal:  Emerg Infect Dis       Date:  2021-12       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.